{"id":"https://openalex.org/W97375821","doi":null,"title":"Approach to the treatment of hyperuricemia.","display_name":"Approach to the treatment of hyperuricemia.","publication_year":2009,"publication_date":"2009-11-01","ids":{"openalex":"https://openalex.org/W97375821","mag":"97375821","pmid":"https://pubmed.ncbi.nlm.nih.gov/19999894"},"language":"en","primary_location":{"id":"pmid:19999894","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/19999894","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Medicine and health, Rhode Island","raw_type":"Journal Article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5043601015","display_name":"Samuel Ho Ting Poon","orcid":"https://orcid.org/0000-0003-1284-7906","observed_orcids":["https://orcid.org/0000-0003-1284-7906"]},"institutions":[{"id":"https://openalex.org/I2800446032","display_name":"Rhode Island Hospital","ror":"https://ror.org/01aw9fv09","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2800446032","https://openalex.org/I4210151747"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Samuel H Poon","raw_affiliation_strings":["Rhode Island Hospital, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Rhode Island Hospital, USA","institution_ids":["https://openalex.org/I2800446032"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030704333","display_name":"Harald A. Hall","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Harald A Hall","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5005162542","display_name":"B Zimmermann","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Bernard Zimmermann","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.6765,"has_fulltext":false,"cited_by_count":14,"citation_normalized_percentile":{"value":0.73184912,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":96},"biblio":{"volume":"92","issue":"11","first_page":"359","last_page":"62"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11139","display_name":"Gout, Hyperuricemia, Uric Acid","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2727","display_name":"Nephrology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11139","display_name":"Gout, Hyperuricemia, Uric Acid","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2727","display_name":"Nephrology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12827","display_name":"Biochemical and Molecular Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11117","display_name":"Drug-Induced Adverse Reactions","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/hyperuricemia","display_name":"hyperuricemia","score":1.0},{"id":"https://openalex.org/keywords/gout","display_name":"gout","score":0.6930000185966492},{"id":"https://openalex.org/keywords/urate-lowering-agents","display_name":"urate-lowering agents","score":0.9049999713897705},{"id":"https://openalex.org/keywords/febuxostat","display_name":"febuxostat","score":0.9639999866485596},{"id":"https://openalex.org/keywords/allopurinol","display_name":"allopurinol","score":0.9950000047683716},{"id":"https://openalex.org/keywords/serum-uric-acid","display_name":"serum uric acid","score":0.8289999961853027},{"id":"https://openalex.org/keywords/uric-acid-metabolism","display_name":"uric acid metabolism","score":0.777999997138977}],"concepts":[{"id":"https://openalex.org/C2780932893","wikidata":"https://www.wikidata.org/wiki/Q417296","display_name":"Febuxostat","level":4,"score":0.995813250541687},{"id":"https://openalex.org/C2779721657","wikidata":"https://www.wikidata.org/wiki/Q49970","display_name":"Hyperuricemia","level":3,"score":0.9654581546783447},{"id":"https://openalex.org/C2780402116","wikidata":"https://www.wikidata.org/wiki/Q133087","display_name":"Gout","level":2,"score":0.9001168012619019},{"id":"https://openalex.org/C2780261098","wikidata":"https://www.wikidata.org/wiki/Q412486","display_name":"Allopurinol","level":2,"score":0.8892625570297241},{"id":"https://openalex.org/C2779881121","wikidata":"https://www.wikidata.org/wiki/Q105522","display_name":"Uric acid","level":2,"score":0.7367125749588013},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6903790831565857},{"id":"https://openalex.org/C2777820942","wikidata":"https://www.wikidata.org/wiki/Q8042974","display_name":"Xanthine oxidase inhibitor","level":4,"score":0.5356767773628235},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.48121073842048645},{"id":"https://openalex.org/C3018890749","wikidata":"https://www.wikidata.org/wiki/Q204711","display_name":"Food and drug administration","level":2,"score":0.4787168502807617},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.3846164345741272},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3049313426017761},{"id":"https://openalex.org/C2778102346","wikidata":"https://www.wikidata.org/wiki/Q412509","display_name":"Xanthine oxidase","level":3,"score":0.17316538095474243},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.16813769936561584},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.14677798748016357},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.07138732075691223}],"mesh":[{"descriptor_ui":"D000069465","descriptor_name":"Febuxostat","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000493","descriptor_name":"Allopurinol","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000493","descriptor_name":"Allopurinol","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D006074","descriptor_name":"Gout Suppressants","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D006074","descriptor_name":"Gout Suppressants","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013844","descriptor_name":"Thiazoles","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D014527","descriptor_name":"Uric Acid","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D014528","descriptor_name":"Uricosuric Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D014969","descriptor_name":"Xanthine Oxidase","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D033461","descriptor_name":"Hyperuricemia","qualifier_ui":"Q000175","qualifier_name":"diagnosis","is_major_topic":false},{"descriptor_ui":"D033461","descriptor_name":"Hyperuricemia","qualifier_ui":"Q000178","qualifier_name":"diet therapy","is_major_topic":false},{"descriptor_ui":"D033461","descriptor_name":"Hyperuricemia","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true}],"locations_count":3,"locations":[{"id":"pmid:19999894","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/19999894","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Medicine and health, Rhode Island","raw_type":"Journal Article"},{"id":"pmh:oai:CiteSeerX.psu:10.1.1.504.8276","doi":null,"is_oa":false,"landing_page_url":"http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.504.8276","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"http://www.rimed.org/medhealthri/2009-11/2009-11-359.pdf","raw_type":"text"},{"id":"mag:97375821","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/19999894","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9537000060081482}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":15,"referenced_works":["https://openalex.org/W1741764841","https://openalex.org/W1864638351","https://openalex.org/W1988636880","https://openalex.org/W2000166571","https://openalex.org/W2020247068","https://openalex.org/W2030766003","https://openalex.org/W2049621329","https://openalex.org/W2052661775","https://openalex.org/W2062112600","https://openalex.org/W2098144815","https://openalex.org/W2119535728","https://openalex.org/W2136525812","https://openalex.org/W2151809600","https://openalex.org/W2156131531","https://openalex.org/W7128173809"],"related_works":["https://openalex.org/W2016825263","https://openalex.org/W2620993627","https://openalex.org/W2163725434","https://openalex.org/W4292196777","https://openalex.org/W7095430386","https://openalex.org/W2009104346","https://openalex.org/W2048639331","https://openalex.org/W2157092954","https://openalex.org/W7095336398","https://openalex.org/W2088792463"],"abstract_inverted_index":{"Despite":[0],"a":[1,21],"sound":[2],"understanding":[3],"of":[4,34,60,65,85],"the":[5,32,41,47,63,78,83],"synthetic":[6],"and":[7,26,49,67,89],"metabolic":[8],"pathways":[9],"that":[10],"control":[11],"serum":[12,86],"uric":[13,87],"acid":[14,88],"levels,":[15],"clinicians":[16],"have":[17],"been":[18],"limited":[19],"to":[20,70],"few":[22],"urate":[23,28,43],"lower-ing":[24],"agents":[25,80],"one":[27],"synthesis":[29,44],"inhibi-tor":[30],"since":[31],"development":[33],"allopurinol":[35],"in":[36,55,62],"1956.1":[37],"Febuxostat":[38],"(Uloric)":[39],"became":[40],"second":[42],"inhibitor":[45],"when":[46],"Food":[48],"Drug":[50],"Administration":[51],"(FDA)":[52],"approved":[53],"it":[54],"early":[56],"2009.":[57],"The":[58],"role":[59],"febuxostat":[61],"management":[64],"hyperuricemia":[66],"gout":[68],"remains":[69],"be":[71],"fully":[72],"determined.":[73],"This":[74],"review":[75],"will":[76],"dis-cuss":[77],"traditional":[79],"used":[81],"for":[82],"lowering":[84],"address":[90]},"counts_by_year":[{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":2},{"year":2014,"cited_by_count":2},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":2}],"updated_date":"2026-11-08T12:12:28.789561","created_date":"2016-06-24T00:00:00"}